Coherus BioSciences Inc (CHRS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -65.156 | -139.65 | -159.753 | 35.34 | 21.149 | -37.752 | -50.295 | -42.846 |
Return on Equity (%) | -2049.69 | -954.8 | 5197.095 | 269.676 | 68.487 | -151.624 | 1470.09 | 143.81 |
Return on Invested Capital (%) | -212.55 | -186.987 | -209.967 | 70.568 | 35.014 | -49.053 | -73.785 | -86.854 |
Operating Margin (%) | -63.022 | -14700.129 | N/A | 30.998 | 32.969 | -80.888 | -122.857 | -76.865 |
Net Profit Margin (%) | -66.982 | -15306.555 | N/A | 25.229 | 27.793 | -87.919 | -138.245 | -92.477 |
Book Value Per Share | 0.345 | 0.451 | -0.617 | 1.445 | 3.826 | 1.224 | -1.818 | -2.38 |
Earnings Per Share | -2.78 | -3.98 | -3.065 | 1.277 | 1.824 | -3.732 | -3.7 | -2.136 |
Cash Per Share | 2.728 | 2.121 | 1.059 | 2.525 | 7.463 | 5.423 | 0.806 | 0.924 |
Working Capital Per Share | 2.295 | 1.957 | 0.749 | 3.241 | 8.575 | 5.68 | 3.076 | 1.292 |
Operating Profit Per Share | 4.15 | 0.026 | N/A | 4.865 | 6.082 | 3.541 | 1.835 | 0.916 |
EBIT Per Share | -2.79 | -3.982 | -3.066 | 1.318 | 1.871 | -3.732 | -3.7 | -2.14 |
EBITDA Per Share | -2.79 | -3.982 | -3.066 | 1.318 | 1.871 | -3.732 | -3.7 | -2.14 |
Free Cash Flow Per Share | -2.703 | -3.961 | -3.101 | 1.256 | 1.884 | -3.76 | -3.721 | -2.168 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 45,81M | 59,84M | 68,3M | 70,37M | 72,51M | 76,93M | 78,85M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 78,85M | N/A | 78,85M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -203.53 | N/A | N/A | N/A | 147.919 | N/A | N/A |
Net Profit Margin (%) | N/A | -233.472 | N/A | N/A | N/A | 133.495 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 164,76M |
Ratio cours/bénéfice | -0,71 |
Ratio prix/ventes | 0,66 |
Ratio prix/liquidités | 1,65 |
Ratio prix/valeur comptable | -0,88 |
Rendement de dividende | - |
Actions en circulation | 115,21M |
Volume moyen (1 semaine) | 3,19M |
Volume moyen (1 mois) | 10,19M |
Variation sur 52 semaines | -28,29% |
Plus haut sur 52 semaines | 3,70 |
Plus bas sur 52 semaines | 0,6603 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales